Journal of Nuclear Cardiology

, Volume 14, Issue 5, pp 634–644

Nuclear cardiology will remain the “gatekeeper” over CT angiography

Editorial Point of View

DOI: 10.1016/j.nuclcard.2007.06.118

Cite this article as:
Hachamovitch, R. & Di Carli, M.F. J Nucl Cardiol (2007) 14: 634. doi:10.1016/j.nuclcard.2007.06.118

Conclusion

Although CTA is a promising new modality, from an evidence-based point of view there is no data to support its use in a testing strategy, its accuracy is unlikely to be sufficiently similar to invasive catheterization to be considered its equivalent, and most importantly, it appears that stress perfusion data will be needed to select which patients may most benefit from revascularization and, hence, referral to the catheterization laboratory.

Copyright information

© American Society of Nuclear Cardiology 2007

Authors and Affiliations

  1. 1.Division of CardiologyNew YorkUSA
  2. 2.Division of Nuclear Medicine/PET, Department of Radiology, Brigham and Women’s HospitalHarvard Medical SchoolBostonUSA
  3. 3.Division of Cardiovascular Imaging, Department of Medicine, Brigham and Women’s HospitalHarvard Medical SchoolBostonUSA
  4. 4.Los Angeles